AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11, 2026.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AstraZeneca Pharma India Limited has informed the stock exchange that a meeting of its Board of Directors was held on February 11, 2026. The filing is a standard regulatory disclosure required under listing norms to intimate the exchange whenever the board convenes. The announcement does not detail any specific decisions, approvals, or financial results from the meeting. Investors will need to wait for the detailed outcome or any separate disclosures for substantive information.
This is a routine compliance filing and is generally neutral for shareholders. Any meaningful decisions taken at the meeting (such as results, dividends, or strategic actions) would be disclosed separately and could then move the stock.